88 related articles for article (PubMed ID: 30067174)
1. GaHV-2 ICP22 protein is expressed from a bicistronic transcript regulated by three GaHV-2 microRNAs.
Boumart I; Figueroa T; Dambrine G; Muylkens B; Pejakovic S; Rasschaert D; Dupuy C
J Gen Virol; 2018 Sep; 99(9):1286-1300. PubMed ID: 30067174
[TBL] [Abstract][Full Text] [Related]
2. mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek's disease virus, targets the immediate-early genes ICP4 and ICP27.
Strassheim S; Stik G; Rasschaert D; Laurent S
J Gen Virol; 2012 Aug; 93(Pt 8):1731-1742. PubMed ID: 22513387
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of Marek's disease virus serotype 1 (MDV1) ICP22 gene product: MDV1 ICP22 transactivates the MDV1 ICP27 promoter synergistically with MDV1 ICP4.
Kato K; Izumiya Y; Tohya Y; Takahashi E; Hirai K; Kawaguchi Y
Vet Microbiol; 2002 Apr; 85(4):305-13. PubMed ID: 11856580
[TBL] [Abstract][Full Text] [Related]
4. Kinetic expression analysis of the cluster mdv1-mir-M9-M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek's disease virus infection.
Coupeau D; Dambrine G; Rasschaert D
J Gen Virol; 2012 Jul; 93(Pt 7):1519-1529. PubMed ID: 22442112
[TBL] [Abstract][Full Text] [Related]
5. Hyperediting by ADAR1 of a new herpesvirus lncRNA during the lytic phase of the oncogenic Marek's disease virus.
Figueroa T; Boumart I; Coupeau D; Rasschaert D
J Gen Virol; 2016 Nov; 97(11):2973-2988. PubMed ID: 27655063
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Marek's disease herpesvirus encodes an isoform of the conserved regulatory immediate early protein ICP27 generated by alternative promoter usage.
Strassheim S; Gennart I; Muylkens B; André M; Rasschaert D; Laurent S
J Gen Virol; 2016 Sep; 97(9):2399-2410. PubMed ID: 27411695
[TBL] [Abstract][Full Text] [Related]
7. Specific transcriptional and post-transcriptional regulation of the major immediate early
Rasschaert P; Gennart I; Boumart I; Dambrine G; Muylkens B; Rasschaert D; Laurent S
J Gen Virol; 2018 Mar; 99(3):355-368. PubMed ID: 29458534
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas.
Zhao P; Li XJ; Teng M; Dang L; Yu ZH; Chi JQ; Su JW; Zhang GP; Luo J
Virus Genes; 2015 Apr; 50(2):245-52. PubMed ID: 25666057
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA Methylation and CpG Sites in the Viral Telomerase RNA Promoter during Gallid Herpesvirus 2 Pathogenesis.
Pejaković S; Mbouombouo Mfossa AC; Wiggers L; Kheimar A; Coupeau D; Kaufer BB; Muylkens B
J Virol; 2020 Nov; 94(23):. PubMed ID: 32967954
[TBL] [Abstract][Full Text] [Related]
10. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
[TBL] [Abstract][Full Text] [Related]
11. The defective interfering particles of equine herpesvirus 1 encode an ICP22/ICP27 hybrid protein that alters viral gene regulation.
Chen M; Garko-Buczynski KA; Zhang Y; O'Callaghan DJ
Virus Res; 1999 Feb; 59(2):149-64. PubMed ID: 10082387
[TBL] [Abstract][Full Text] [Related]
12. Vaccine and oncogenic strains of gallid herpesvirus 2 contain specific subtype variations in the 5' region of the latency-associated transcript that evolve in vitro and in vivo.
Labaille J; Lion A; Boissel E; Trapp S; Nair V; Rasschaert D; Dambrine G
Arch Virol; 2015 Jan; 160(1):161-71. PubMed ID: 25298182
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.
Stik G; Dambrine G; Pfeffer S; Rasschaert D
J Virol; 2013 Jan; 87(1):80-93. PubMed ID: 23055556
[TBL] [Abstract][Full Text] [Related]
14. Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus.
Bowman JJ; Orlando JS; Davido DJ; Kushnir AS; Schaffer PA
J Virol; 2009 Sep; 83(17):8733-43. PubMed ID: 19535441
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the regulatory function of the ICP22 protein of equine herpesvirus type 1.
Holden VR; Zhao Y; Thompson Y; Caughman GB; Smith RH; O'Callaghan DJ
Virology; 1995 Jul; 210(2):273-82. PubMed ID: 7618267
[TBL] [Abstract][Full Text] [Related]
16. Characterization of herpes simplex virus 2 primary microRNA Transcript regulation.
Tang S; Bosch-Marce M; Patel A; Margolis TP; Krause PR
J Virol; 2015 May; 89(9):4837-48. PubMed ID: 25673716
[TBL] [Abstract][Full Text] [Related]
17. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.
Muylkens B; Coupeau D; Dambrine G; Trapp S; Rasschaert D
Arch Virol; 2010 Nov; 155(11):1823-37. PubMed ID: 20680360
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.
Shkreli M; Dambrine G; Soubieux D; Kut E; Rasschaert D
J Virol; 2007 May; 81(9):4848-57. PubMed ID: 17314164
[TBL] [Abstract][Full Text] [Related]
19. Roles of avian herpesvirus microRNAs in infection, latency, and oncogenesis.
Morgan RW; Burnside J
Biochim Biophys Acta; 2011; 1809(11-12):654-9. PubMed ID: 21683170
[TBL] [Abstract][Full Text] [Related]
20. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
Omar AR; Schat KA
Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
